Fintel reports that on January 8, 2025, Stifel initiated coverage of Altimmune (NasdaqGM:ALT) with a Buy recommendation.

DoubleVerify Holding (NYSE:DV) shares jumped 6% by noon trading on Wednesday after it was revealed by Stifel that the ...

Stifel analysts raised their price target to $31.00 from $26.00 and reiterated a Buy rating on Rocket Lab ( RKLB, Financial) ...

In a report released today, Cole McGill from Stifel Nicolaus maintained a Buy rating on Lithium Americas Corp. (LAC – Research Report), with a ...

The analyst's findings offer a glimpse into DoubleVerify's business strategy, potentially signaling a stronger financial outlook for the company if the price increase is implemented. The news has ...

Stifel resumed coverage of Beacon (BECN) with a Buy rating and $115 price target Amid the “robust” valuations prevailing across building ...

European defence sector stocks rose on Wednesday after U.S. President-elect Donald Trump called for higher spending from NATO ...